Survival of prostate cancer patients in central and northern Denmark, 1998-2009

Clinical Epidemiology

Volumn 3, Issue SUPPL., 2011, Pages 41-46

  Borre, Michael ^a   Erichsen, Rune ^a   Lund, Lars ^b   Larsen, Erik Højkjær ^a   Nørgaard, Mette ^a   Jacobsen, Jacob Bonde ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b VIBORG HOSPITAL   (Denmark)

Author keywords

Mortality rate ratio; MRR; Outcome research

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; HOSPITALIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PROSTATE CANCER; SURVIVAL RATE;

EID: 80955124045     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/clep.s20625     Document Type: Article

References (23)

1. The National Board of Health. The Danish registry of death causes 2009 [in Danish]. Available from: http://www.sst.dk/publ/Publ2010/DOKU/Registre/Doedsaarsagsregisteret2009.pdf. Accessed May 18, 2011.
2. The National Board of Health. Cancer incidence in Denmark 2009 [in Danish]. Available from: http://www.sst.dk/publ/Publ2010/DOKU/Registre/Cancerregisteret2009.pdf. Accessed May 18, 2011.
3. Brett TD. An analysis of digital examination and serum-prostate-specific antigen in the early detection of prostate cancer in general practice. Fam Pract. 1998;15:529-533.
4. Feneley MR, Brewster S. Opportunities and outcomes in early prostate cancer: a commentary on policy, patient perspectives, trials and strategies. BJU Int. 2003;91:177-178.
5. Jønler M, Eddy B, Poulsen J. Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark. Scand J Urol Nephrol. 2005;39:214-218.
6. Ostersen TM, Bro F, Pedersen KV, Vedsted P. Use of prostate-specific antigen testing. Ugeskr Læger. 2010;172(9):696-700.
7. Borre M, Iversen P, Bendixen A, Iversen MG, Kehlet H. Organisation and early outcome after radical prostatectomy in Denmark 2004-2007. Ugeskr Laeger. 2008;170(34):2545-2549.
8. Lund L, Jacobsen J, Borre M, et al. Improved survival of patients with prostate cancer in Northern Denmark, 1985-2004. Scand J Urol and Nephr. 2007;41:308-313.
9. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A Valuable Source of Data for Modern Health Sciences. Dan Med Bull. 1999;46:263-268.
10. Pedersen CB, Gotzsche H, Moller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull. 2006;53:441-449.
11. Brenner H, Rachet B. Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases. Eur J Cancer. 2004;40:2491-2501.
12. Storm HH. Completeness of cancer registration in Denmark 1943-1966 and efficacy of record linkage procedures. Int J Epidemiol. 1988;17:44-49.
13. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry history, content, quality and use. Dan Med Bull. 1997;44:535-539.
14. Tetsche MS, Nørgaard M, Skriver MV, Andersen ES, Lash TL, Sørensen HT. Accuracy of ovarian cancer ICD-10 diagnosis in a Danish population-based hospital discharge registry. Eur J Gyn Oncol. 2005;26:266-270.
15. Bray F, Klint A, Gislum M, et al. Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006. Acta Oncol. Jun 2010;49(5):644-654.
16. Storm HH, Gislum M, Kejs AM, Engholm G. Survival of Danish cancer patients 1995-2006. Ugeskr Laeger. 2010;172(33):2213-2217.
17. Tretli S, Haldorsen A, Hakulinen T, et al. Prostate cancer - look to Denmark? J Natl Can Inst. 1996;88:128.
18. Holmberg L, Bill-Axelsson A, Helgesen F, et al. A randomised trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med. 2002;347:781-789.
19. Schröder FH, Hugosson J, Roobol MJ, et al; for the ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360(13):1320-1328.
20. Møller H. Trends in incidence of testicular cancer and prostate cancer in Denmark. Human Reprod. 2001;16:1007-1011.
21. Coleman MP, Gatta G, Verdecchia A, et al; EUROCARE Working Group. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol. 2003;14 Suppl 5:v128-v149.
22. Micheli A, Coebergh JW, Mugno E, et al; and the EUROCARE Working group. European health systems and cancer care. Ann Oncol. 2003;14:41-60.
23. Gjertson CK, Albertsen PC. Use and assessment of PSA in prostate cancer. Med Clin North Am. 2011;95(1):191-200.